MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹541 Cr | ₹333 Cr | ₹241 Cr | ₹290 Cr | ₹167 Cr |
What is the latest Total Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹541 Cr |
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹241 Cr |
| Mar2023 | ₹290 Cr |
| Mar2022 | ₹167 Cr |
How is Total Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹541 Cr | 62.64 | |
| Mar2025 | ₹333 Cr | 38.03 | |
| Mar2024 | ₹241 Cr | -16.89 | |
| Mar2023 | ₹290 Cr | 74.27 | |
| Mar2022 | ₹167 Cr | - | |
Compare Total Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹560.3 Cr | -1.7% | 2.2% | 23.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,722.7 Cr | -0.6% | -1.8% | -30.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,064.9 Cr | -5.6% | -11.5% | 8% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,569.1 Cr | 6.9% | 12.7% | 44.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹892.0 Cr | -3% | -6.2% | NA | Stock Analytics | |
| NATH BIOGENES (INDIA) | ₹254.7 Cr | -6.6% | 0.8% | -19.3% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -1.7% |
2.2% |
23.1% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses